nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—CYP2D6—Temsirolimus—kidney cancer	0.145	0.372	CbGbCtD
Hydroxychloroquine—CYP2D6—Pazopanib—kidney cancer	0.0759	0.195	CbGbCtD
Hydroxychloroquine—CYP2D6—Erlotinib—kidney cancer	0.0542	0.139	CbGbCtD
Hydroxychloroquine—CYP2D6—Sorafenib—kidney cancer	0.044	0.113	CbGbCtD
Hydroxychloroquine—CYP2D6—Vinblastine—kidney cancer	0.0435	0.112	CbGbCtD
Hydroxychloroquine—CYP2D6—Doxorubicin—kidney cancer	0.0267	0.0687	CbGbCtD
Hydroxychloroquine—Primaquine—KRT7—kidney cancer	0.00955	0.634	CrCbGaD
Hydroxychloroquine—Primaquine—CYP1A1—kidney cancer	0.00175	0.116	CrCbGaD
Hydroxychloroquine—Amodiaquine—CYP1A1—kidney cancer	0.00148	0.0985	CrCbGaD
Hydroxychloroquine—Chloroquine—CYP1A1—kidney cancer	0.00107	0.0712	CrCbGaD
Hydroxychloroquine—Quinacrine—ABCB1—kidney cancer	0.000643	0.0427	CrCbGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—MAPK3—kidney cancer	0.000614	0.00303	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CTSB—kidney cancer	0.000614	0.00303	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—TXNIP—kidney cancer	0.000613	0.00302	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—MAPK3—kidney cancer	0.000609	0.003	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CARD11—kidney cancer	0.000601	0.00297	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—MAPK1—kidney cancer	0.000601	0.00296	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—OR4C13—kidney cancer	0.000596	0.00294	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK1—kidney cancer	0.000595	0.00294	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—MAPK3—kidney cancer	0.000593	0.00292	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—MAPK3—kidney cancer	0.000593	0.00292	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—MAPK3—kidney cancer	0.000593	0.00292	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—RELA—kidney cancer	0.000588	0.0029	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—MAPK1—kidney cancer	0.000584	0.00288	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—MAPK1—kidney cancer	0.000584	0.00288	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—RELA—kidney cancer	0.000582	0.00287	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—MAPK1—kidney cancer	0.000579	0.00286	CbGpPWpGaD
Hydroxychloroquine—Chloroquine—ABCB1—kidney cancer	0.00057	0.0378	CrCbGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—PIK3CA—kidney cancer	0.00057	0.00281	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—KRAS—kidney cancer	0.000567	0.0028	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—MAPK1—kidney cancer	0.000564	0.00278	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—MAPK1—kidney cancer	0.000564	0.00278	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—MAPK1—kidney cancer	0.000564	0.00278	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—TCEB2—kidney cancer	0.000561	0.00276	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—TCEB1—kidney cancer	0.000561	0.00276	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—ITPR2—kidney cancer	0.000559	0.00276	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—KRAS—kidney cancer	0.000552	0.00272	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—KRAS—kidney cancer	0.000547	0.0027	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—MAPK3—kidney cancer	0.000546	0.00269	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—MAPK3—kidney cancer	0.000539	0.00266	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—KEAP1—kidney cancer	0.000536	0.00264	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—MAPK3—kidney cancer	0.000533	0.00263	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—KRAS—kidney cancer	0.000533	0.00263	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—KRAS—kidney cancer	0.000533	0.00263	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—PAK1—kidney cancer	0.000532	0.00262	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD274—kidney cancer	0.00053	0.00261	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—PIK3CA—kidney cancer	0.000521	0.00257	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—MAPK1—kidney cancer	0.000519	0.00256	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—IFNA1—kidney cancer	0.000519	0.00256	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—JUN—kidney cancer	0.000515	0.00254	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—MAPK1—kidney cancer	0.000513	0.00253	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—JUN—kidney cancer	0.00051	0.00251	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—PIK3CA—kidney cancer	0.000507	0.0025	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—LATS1—kidney cancer	0.000507	0.0025	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—MAPK1—kidney cancer	0.000507	0.0025	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Melatonin metabolism and effects—CYP1A1—kidney cancer	0.000507	0.0025	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—VHL—kidney cancer	0.000505	0.00249	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—PIK3CA—kidney cancer	0.000502	0.00248	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—MAPK3—kidney cancer	0.000492	0.00243	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—PIK3CA—kidney cancer	0.000489	0.00241	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—PIK3CA—kidney cancer	0.000489	0.00241	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CTSB—kidney cancer	0.000485	0.00239	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CASP2—kidney cancer	0.000484	0.00239	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—TXNIP—kidney cancer	0.000484	0.00239	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—IFNA2—kidney cancer	0.000483	0.00238	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—MAPK1—kidney cancer	0.000468	0.00231	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD34—kidney cancer	0.000464	0.00229	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—PIK3CA—kidney cancer	0.000451	0.00222	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—PIK3CA—kidney cancer	0.000445	0.00219	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CARD11—kidney cancer	0.000443	0.00219	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—TCEB2—kidney cancer	0.000443	0.00219	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—TCEB1—kidney cancer	0.000443	0.00219	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—KRAS—kidney cancer	0.000442	0.00218	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—AMER1—kidney cancer	0.000431	0.00213	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—MAPK3—kidney cancer	0.000426	0.0021	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—KEAP1—kidney cancer	0.000423	0.00209	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—MAPK3—kidney cancer	0.000421	0.00208	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PAK1—kidney cancer	0.000421	0.00207	CbGpPWpGaD
Hydroxychloroquine—Weight decreased—Capecitabine—kidney cancer	0.000415	0.00106	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—ITPR2—kidney cancer	0.000412	0.00203	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Sunitinib—kidney cancer	0.000412	0.00105	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—IFNA1—kidney cancer	0.00041	0.00202	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000409	0.00104	CcSEcCtD
Hydroxychloroquine—Asthenia—Vinblastine—kidney cancer	0.000408	0.00104	CcSEcCtD
Hydroxychloroquine—Fatigue—Sunitinib—kidney cancer	0.000408	0.00104	CcSEcCtD
Hydroxychloroquine—Depression—Capecitabine—kidney cancer	0.000408	0.00104	CcSEcCtD
Hydroxychloroquine—Asthenia—Everolimus—kidney cancer	0.000407	0.00103	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—PIK3CA—kidney cancer	0.000406	0.002	CbGpPWpGaD
Hydroxychloroquine—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000406	0.00103	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—MAPK1—kidney cancer	0.000405	0.002	CbGpPWpGaD
Hydroxychloroquine—Pain—Sunitinib—kidney cancer	0.000405	0.00103	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Sorafenib—kidney cancer	0.000403	0.00102	CcSEcCtD
Hydroxychloroquine—Pruritus—Everolimus—kidney cancer	0.000401	0.00102	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—MAPK1—kidney cancer	0.000401	0.00198	CbGpPWpGaD
Hydroxychloroquine—Oedema—Vincristine—kidney cancer	0.000401	0.00102	CcSEcCtD
Hydroxychloroquine—Alopecia—Paclitaxel—kidney cancer	0.000396	0.00101	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000394	0.001	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Vincristine—kidney cancer	0.000393	0.000999	CcSEcCtD
Hydroxychloroquine—Asthenia—Erlotinib—kidney cancer	0.000393	0.000998	CcSEcCtD
Hydroxychloroquine—Mental disorder—Paclitaxel—kidney cancer	0.000392	0.000998	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Vincristine—kidney cancer	0.000392	0.000997	CcSEcCtD
Hydroxychloroquine—Hepatic function abnormal—Doxorubicin—kidney cancer	0.000392	0.000996	CcSEcCtD
Hydroxychloroquine—Urticaria—Sorafenib—kidney cancer	0.000391	0.000994	CcSEcCtD
Hydroxychloroquine—Photosensitivity—Doxorubicin—kidney cancer	0.00039	0.000992	CcSEcCtD
Hydroxychloroquine—Malnutrition—Paclitaxel—kidney cancer	0.00039	0.000991	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Dactinomycin—kidney cancer	0.00039	0.000991	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Vinblastine—kidney cancer	0.000389	0.00099	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Sorafenib—kidney cancer	0.000389	0.000989	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Sorafenib—kidney cancer	0.000389	0.000989	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Everolimus—kidney cancer	0.000388	0.000987	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Sunitinib—kidney cancer	0.000387	0.000985	CcSEcCtD
Hydroxychloroquine—Pruritus—Erlotinib—kidney cancer	0.000387	0.000984	CcSEcCtD
Hydroxychloroquine—Fatigue—Dactinomycin—kidney cancer	0.000387	0.000983	CcSEcCtD
Hydroxychloroquine—Pain—Dactinomycin—kidney cancer	0.000383	0.000975	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CASP2—kidney cancer	0.000383	0.00189	CbGpPWpGaD
Hydroxychloroquine—Tension—Paclitaxel—kidney cancer	0.000383	0.000973	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Capecitabine—kidney cancer	0.000382	0.000972	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—IFNA2—kidney cancer	0.000382	0.00188	CbGpPWpGaD
Hydroxychloroquine—Anorexia—Vincristine—kidney cancer	0.000382	0.000971	CcSEcCtD
Hydroxychloroquine—Oedema—Gemcitabine—kidney cancer	0.00038	0.000966	CcSEcCtD
Hydroxychloroquine—Nervousness—Paclitaxel—kidney cancer	0.000379	0.000963	CcSEcCtD
Hydroxychloroquine—Dizziness—Vinblastine—kidney cancer	0.000376	0.000957	CcSEcCtD
Hydroxychloroquine—Dizziness—Everolimus—kidney cancer	0.000375	0.000954	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Sunitinib—kidney cancer	0.000374	0.000952	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Sunitinib—kidney cancer	0.000374	0.000952	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Erlotinib—kidney cancer	0.000374	0.000952	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Gemcitabine—kidney cancer	0.000373	0.000948	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Gemcitabine—kidney cancer	0.000372	0.000946	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Capecitabine—kidney cancer	0.000369	0.000939	CcSEcCtD
Hydroxychloroquine—Skin disorder—Gemcitabine—kidney cancer	0.000369	0.000939	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Capecitabine—kidney cancer	0.000368	0.000935	CcSEcCtD
Hydroxychloroquine—Vision blurred—Paclitaxel—kidney cancer	0.000367	0.000934	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CD34—kidney cancer	0.000367	0.00181	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000367	0.000932	CcSEcCtD
Hydroxychloroquine—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000363	0.000923	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Sorafenib—kidney cancer	0.000363	0.000922	CcSEcCtD
Hydroxychloroquine—Anorexia—Gemcitabine—kidney cancer	0.000362	0.000921	CcSEcCtD
Hydroxychloroquine—Vomiting—Vinblastine—kidney cancer	0.000362	0.00092	CcSEcCtD
Hydroxychloroquine—Dizziness—Erlotinib—kidney cancer	0.000362	0.00092	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—GPC3—kidney cancer	0.000361	0.00178	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CER1—kidney cancer	0.000361	0.00178	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Everolimus—kidney cancer	0.000361	0.000917	CcSEcCtD
Hydroxychloroquine—Anaemia—Paclitaxel—kidney cancer	0.00036	0.000916	CcSEcCtD
Hydroxychloroquine—Dermatitis bullous—Doxorubicin—kidney cancer	0.000358	0.000911	CcSEcCtD
Hydroxychloroquine—Agitation—Paclitaxel—kidney cancer	0.000358	0.000911	CcSEcCtD
Hydroxychloroquine—Rash—Everolimus—kidney cancer	0.000358	0.000909	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CTSB—kidney cancer	0.000357	0.00176	CbGpPWpGaD
Hydroxychloroquine—Dermatitis—Everolimus—kidney cancer	0.000357	0.000908	CcSEcCtD
Hydroxychloroquine—Headache—Vinblastine—kidney cancer	0.000357	0.000907	CcSEcCtD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000356	0.00176	CbGpPWpGaD
Hydroxychloroquine—Angioedema—Paclitaxel—kidney cancer	0.000356	0.000906	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CTSD—kidney cancer	0.000356	0.00175	CbGpPWpGaD
Hydroxychloroquine—Headache—Everolimus—kidney cancer	0.000355	0.000903	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Dactinomycin—kidney cancer	0.000354	0.000901	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Dactinomycin—kidney cancer	0.000354	0.000901	CcSEcCtD
Hydroxychloroquine—Visual impairment—Capecitabine—kidney cancer	0.000354	0.000901	CcSEcCtD
Hydroxychloroquine—Asthenia—Sorafenib—kidney cancer	0.000353	0.000898	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—PIK3CA—kidney cancer	0.000352	0.00173	CbGpPWpGaD
Hydroxychloroquine—Cardiac failure—Doxorubicin—kidney cancer	0.000351	0.000892	CcSEcCtD
Hydroxychloroquine—Hypoglycaemia—Doxorubicin—kidney cancer	0.000351	0.000892	CcSEcCtD
Hydroxychloroquine—Vertigo—Paclitaxel—kidney cancer	0.00035	0.000891	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CARD11—kidney cancer	0.00035	0.00173	CbGpPWpGaD
Hydroxychloroquine—Leukopenia—Paclitaxel—kidney cancer	0.000349	0.000887	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Sunitinib—kidney cancer	0.000349	0.000887	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Vincristine—kidney cancer	0.000348	0.000886	CcSEcCtD
Hydroxychloroquine—Pruritus—Sorafenib—kidney cancer	0.000348	0.000886	CcSEcCtD
Hydroxychloroquine—Vomiting—Erlotinib—kidney cancer	0.000348	0.000885	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Capecitabine—kidney cancer	0.000348	0.000884	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Vincristine—kidney cancer	0.000346	0.00088	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—TSC2—kidney cancer	0.000345	0.0017	CbGpPWpGaD
Hydroxychloroquine—Fatigue—Vincristine—kidney cancer	0.000345	0.000878	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—PSMD7—kidney cancer	0.000345	0.0017	CbGpPWpGaD
Hydroxychloroquine—Rash—Erlotinib—kidney cancer	0.000345	0.000877	CcSEcCtD
Hydroxychloroquine—Dermatitis—Erlotinib—kidney cancer	0.000345	0.000876	CcSEcCtD
Hydroxychloroquine—CYP2D6—Biological oxidations—ALDH1A1—kidney cancer	0.000344	0.00169	CbGpPWpGaD
Hydroxychloroquine—Eye disorder—Capecitabine—kidney cancer	0.000343	0.000873	CcSEcCtD
Hydroxychloroquine—Headache—Erlotinib—kidney cancer	0.000343	0.000872	CcSEcCtD
Hydroxychloroquine—Tinnitus—Capecitabine—kidney cancer	0.000343	0.000871	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Paclitaxel—kidney cancer	0.000343	0.000871	CcSEcCtD
Hydroxychloroquine—Pain—Vincristine—kidney cancer	0.000343	0.000871	CcSEcCtD
Hydroxychloroquine—Asthenia—Sunitinib—kidney cancer	0.00034	0.000864	CcSEcCtD
Hydroxychloroquine—Nausea—Vinblastine—kidney cancer	0.000338	0.00086	CcSEcCtD
Hydroxychloroquine—Somnolence—Gemcitabine—kidney cancer	0.000338	0.000859	CcSEcCtD
Hydroxychloroquine—Convulsion—Paclitaxel—kidney cancer	0.000338	0.000859	CcSEcCtD
Hydroxychloroquine—Affect lability—Doxorubicin—kidney cancer	0.000337	0.000857	CcSEcCtD
Hydroxychloroquine—Nausea—Everolimus—kidney cancer	0.000337	0.000857	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Sorafenib—kidney cancer	0.000337	0.000856	CcSEcCtD
Hydroxychloroquine—Pruritus—Sunitinib—kidney cancer	0.000335	0.000852	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Gemcitabine—kidney cancer	0.00033	0.00084	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Dactinomycin—kidney cancer	0.00033	0.00084	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.00033	0.000838	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000328	0.000834	CcSEcCtD
Hydroxychloroquine—Fatigue—Gemcitabine—kidney cancer	0.000328	0.000833	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Vincristine—kidney cancer	0.000328	0.000833	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—ITPR2—kidney cancer	0.000326	0.00161	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Sorafenib—kidney cancer	0.000325	0.000828	CcSEcCtD
Hydroxychloroquine—Pain—Gemcitabine—kidney cancer	0.000325	0.000826	CcSEcCtD
Hydroxychloroquine—Nausea—Erlotinib—kidney cancer	0.000325	0.000826	CcSEcCtD
Hydroxychloroquine—Alopecia—Capecitabine—kidney cancer	0.000325	0.000826	CcSEcCtD
Hydroxychloroquine—Mood swings—Doxorubicin—kidney cancer	0.000324	0.000825	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Sunitinib—kidney cancer	0.000324	0.000824	CcSEcCtD
Hydroxychloroquine—Ataxia—Doxorubicin—kidney cancer	0.000322	0.000819	CcSEcCtD
Hydroxychloroquine—Mental disorder—Capecitabine—kidney cancer	0.000322	0.000819	CcSEcCtD
Hydroxychloroquine—Asthenia—Dactinomycin—kidney cancer	0.000322	0.000818	CcSEcCtD
Hydroxychloroquine—Malnutrition—Capecitabine—kidney cancer	0.00032	0.000814	CcSEcCtD
Hydroxychloroquine—Oedema—Paclitaxel—kidney cancer	0.000318	0.000809	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Vincristine—kidney cancer	0.000317	0.000805	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Vincristine—kidney cancer	0.000317	0.000805	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Doxorubicin—kidney cancer	0.000316	0.000804	CcSEcCtD
Hydroxychloroquine—Dizziness—Sunitinib—kidney cancer	0.000313	0.000796	CcSEcCtD
Hydroxychloroquine—Vomiting—Sorafenib—kidney cancer	0.000313	0.000796	CcSEcCtD
Hydroxychloroquine—Abdominal pain upper—Doxorubicin—kidney cancer	0.000313	0.000795	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Paclitaxel—kidney cancer	0.000312	0.000794	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Paclitaxel—kidney cancer	0.000312	0.000792	CcSEcCtD
Hydroxychloroquine—Rash—Sorafenib—kidney cancer	0.00031	0.000789	CcSEcCtD
Hydroxychloroquine—Dermatitis—Sorafenib—kidney cancer	0.00031	0.000788	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—PAK1—kidney cancer	0.00031	0.00153	CbGpPWpGaD
Hydroxychloroquine—Skin disorder—Paclitaxel—kidney cancer	0.000309	0.000786	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000308	0.000784	CcSEcCtD
Hydroxychloroquine—Headache—Sorafenib—kidney cancer	0.000308	0.000784	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—SFRP2—kidney cancer	0.000307	0.00151	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Dactinomycin—kidney cancer	0.000307	0.00078	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—KIT—kidney cancer	0.000305	0.0015	CbGpPWpGaD
Hydroxychloroquine—Anorexia—Paclitaxel—kidney cancer	0.000303	0.000771	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—IFNA1—kidney cancer	0.000302	0.00149	CbGpPWpGaD
Hydroxychloroquine—Muscular weakness—Doxorubicin—kidney cancer	0.000302	0.000768	CcSEcCtD
Hydroxychloroquine—Vision blurred—Capecitabine—kidney cancer	0.000302	0.000767	CcSEcCtD
Hydroxychloroquine—Vomiting—Sunitinib—kidney cancer	0.000301	0.000766	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Gemcitabine—kidney cancer	0.0003	0.000764	CcSEcCtD
Hydroxychloroquine—Rash—Sunitinib—kidney cancer	0.000299	0.000759	CcSEcCtD
Hydroxychloroquine—Dermatitis—Sunitinib—kidney cancer	0.000298	0.000759	CcSEcCtD
Hydroxychloroquine—Headache—Sunitinib—kidney cancer	0.000297	0.000755	CcSEcCtD
Hydroxychloroquine—Anaemia—Capecitabine—kidney cancer	0.000296	0.000752	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Vincristine—kidney cancer	0.000295	0.000751	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Doxorubicin—kidney cancer	0.000293	0.000745	CcSEcCtD
Hydroxychloroquine—Nausea—Sorafenib—kidney cancer	0.000292	0.000743	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—EGR1—kidney cancer	0.00029	0.00143	CbGpPWpGaD
Hydroxychloroquine—Vertigo—Capecitabine—kidney cancer	0.000287	0.000731	CcSEcCtD
Hydroxychloroquine—Asthenia—Vincristine—kidney cancer	0.000287	0.000731	CcSEcCtD
Hydroxychloroquine—Leukopenia—Capecitabine—kidney cancer	0.000286	0.000728	CcSEcCtD
Hydroxychloroquine—Vomiting—Dactinomycin—kidney cancer	0.000285	0.000725	CcSEcCtD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000283	0.0014	CbGpPWpGaD
Hydroxychloroquine—Somnolence—Paclitaxel—kidney cancer	0.000283	0.000719	CcSEcCtD
Hydroxychloroquine—Rash—Dactinomycin—kidney cancer	0.000283	0.000719	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CTSB—kidney cancer	0.000283	0.00139	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IFNA2—kidney cancer	0.000281	0.00139	CbGpPWpGaD
Hydroxychloroquine—Nausea—Sunitinib—kidney cancer	0.000281	0.000715	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Capecitabine—kidney cancer	0.000281	0.000715	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Doxorubicin—kidney cancer	0.000281	0.000715	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CTSD—kidney cancer	0.000281	0.00139	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000279	0.00138	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Paclitaxel—kidney cancer	0.000277	0.000703	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000275	0.000699	CcSEcCtD
Hydroxychloroquine—Fatigue—Paclitaxel—kidney cancer	0.000274	0.000698	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Vincristine—kidney cancer	0.000274	0.000697	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—TSC2—kidney cancer	0.000273	0.00135	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PSMD7—kidney cancer	0.000273	0.00135	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Gemcitabine—kidney cancer	0.000273	0.000693	CcSEcCtD
Hydroxychloroquine—Pain—Paclitaxel—kidney cancer	0.000272	0.000692	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000271	0.000688	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Doxorubicin—kidney cancer	0.00027	0.000687	CcSEcCtD
Hydroxychloroquine—Pruritus—Gemcitabine—kidney cancer	0.000269	0.000684	CcSEcCtD
Hydroxychloroquine—Weight decreased—Doxorubicin—kidney cancer	0.000268	0.000681	CcSEcCtD
Hydroxychloroquine—Nausea—Dactinomycin—kidney cancer	0.000266	0.000677	CcSEcCtD
Hydroxychloroquine—Dizziness—Vincristine—kidney cancer	0.000265	0.000674	CcSEcCtD
Hydroxychloroquine—Drowsiness—Doxorubicin—kidney cancer	0.000264	0.000671	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000262	0.000665	CcSEcCtD
Hydroxychloroquine—Oedema—Capecitabine—kidney cancer	0.000261	0.000664	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00026	0.000662	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Gemcitabine—kidney cancer	0.00026	0.000661	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Capecitabine—kidney cancer	0.000256	0.000651	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Capecitabine—kidney cancer	0.000256	0.00065	CcSEcCtD
Hydroxychloroquine—Vomiting—Vincristine—kidney cancer	0.000255	0.000648	CcSEcCtD
Hydroxychloroquine—Skin disorder—Capecitabine—kidney cancer	0.000254	0.000645	CcSEcCtD
Hydroxychloroquine—Urticaria—Paclitaxel—kidney cancer	0.000253	0.000643	CcSEcCtD
Hydroxychloroquine—Rash—Vincristine—kidney cancer	0.000253	0.000642	CcSEcCtD
Hydroxychloroquine—Dermatitis—Vincristine—kidney cancer	0.000252	0.000642	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Paclitaxel—kidney cancer	0.000252	0.00064	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Paclitaxel—kidney cancer	0.000252	0.00064	CcSEcCtD
Hydroxychloroquine—Headache—Vincristine—kidney cancer	0.000251	0.000638	CcSEcCtD
Hydroxychloroquine—Anorexia—Capecitabine—kidney cancer	0.000249	0.000633	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—AKAP13—kidney cancer	0.000248	0.00122	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CASP2—kidney cancer	0.000248	0.00122	CbGpPWpGaD
Hydroxychloroquine—Agranulocytosis—Doxorubicin—kidney cancer	0.000246	0.000626	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—PAK1—kidney cancer	0.000245	0.00121	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Gemcitabine—kidney cancer	0.000242	0.000614	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—KIT—kidney cancer	0.000241	0.00119	CbGpPWpGaD
Hydroxychloroquine—Rash—Gemcitabine—kidney cancer	0.00024	0.000609	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—RAF1—kidney cancer	0.000239	0.00118	CbGpPWpGaD
Hydroxychloroquine—Dermatitis—Gemcitabine—kidney cancer	0.000239	0.000609	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—IFNA1—kidney cancer	0.000239	0.00118	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—RELA—kidney cancer	0.000238	0.00118	CbGpPWpGaD
Hydroxychloroquine—Haemoglobin—Doxorubicin—kidney cancer	0.000238	0.000606	CcSEcCtD
Hydroxychloroquine—Headache—Gemcitabine—kidney cancer	0.000238	0.000605	CcSEcCtD
Hydroxychloroquine—Nausea—Vincristine—kidney cancer	0.000238	0.000605	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Doxorubicin—kidney cancer	0.000237	0.000602	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—ERBB2—kidney cancer	0.000237	0.00117	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD8A—kidney cancer	0.000237	0.00117	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Paclitaxel—kidney cancer	0.000234	0.000596	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—MTOR—kidney cancer	0.000234	0.00115	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CD4—kidney cancer	0.000233	0.00115	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.00023	0.00113	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—EGR1—kidney cancer	0.000229	0.00113	CbGpPWpGaD
Hydroxychloroquine—Visual impairment—Doxorubicin—kidney cancer	0.000228	0.000581	CcSEcCtD
Hydroxychloroquine—Asthenia—Paclitaxel—kidney cancer	0.000228	0.000581	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Capecitabine—kidney cancer	0.000227	0.000577	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—GRB7—kidney cancer	0.000226	0.00112	CbGpPWpGaD
Hydroxychloroquine—Nausea—Gemcitabine—kidney cancer	0.000226	0.000574	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000225	0.000573	CcSEcCtD
Hydroxychloroquine—Fatigue—Capecitabine—kidney cancer	0.000225	0.000572	CcSEcCtD
Hydroxychloroquine—Pruritus—Paclitaxel—kidney cancer	0.000225	0.000572	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Doxorubicin—kidney cancer	0.000224	0.00057	CcSEcCtD
Hydroxychloroquine—Pain—Capecitabine—kidney cancer	0.000223	0.000568	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—IFNA2—kidney cancer	0.000222	0.0011	CbGpPWpGaD
Hydroxychloroquine—Eye disorder—Doxorubicin—kidney cancer	0.000221	0.000563	CcSEcCtD
Hydroxychloroquine—Tinnitus—Doxorubicin—kidney cancer	0.000221	0.000562	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—CDKN1B—kidney cancer	0.000219	0.00108	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Paclitaxel—kidney cancer	0.000218	0.000554	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Capecitabine—kidney cancer	0.000214	0.000543	CcSEcCtD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000211	0.00104	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ITPR2—kidney cancer	0.000211	0.00104	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Paclitaxel—kidney cancer	0.00021	0.000535	CcSEcCtD
Hydroxychloroquine—Alopecia—Doxorubicin—kidney cancer	0.000209	0.000532	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—JUN—kidney cancer	0.000209	0.00103	CbGpPWpGaD
Hydroxychloroquine—Mental disorder—Doxorubicin—kidney cancer	0.000208	0.000528	CcSEcCtD
Hydroxychloroquine—Urticaria—Capecitabine—kidney cancer	0.000207	0.000528	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—CTNNB1—kidney cancer	0.000207	0.00102	CbGpPWpGaD
Hydroxychloroquine—Body temperature increased—Capecitabine—kidney cancer	0.000206	0.000525	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Capecitabine—kidney cancer	0.000206	0.000525	CcSEcCtD
Hydroxychloroquine—Malnutrition—Doxorubicin—kidney cancer	0.000206	0.000524	CcSEcCtD
Hydroxychloroquine—Tension—Doxorubicin—kidney cancer	0.000202	0.000515	CcSEcCtD
Hydroxychloroquine—Vomiting—Paclitaxel—kidney cancer	0.000202	0.000514	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—PTEN—kidney cancer	0.000202	0.000996	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—GSTT1—kidney cancer	0.000202	0.000996	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—TSC2—kidney cancer	0.000201	0.000992	CbGpPWpGaD
Hydroxychloroquine—Rash—Paclitaxel—kidney cancer	0.000201	0.00051	CcSEcCtD
Hydroxychloroquine—Dermatitis—Paclitaxel—kidney cancer	0.0002	0.00051	CcSEcCtD
Hydroxychloroquine—Nervousness—Doxorubicin—kidney cancer	0.0002	0.000509	CcSEcCtD
Hydroxychloroquine—Headache—Paclitaxel—kidney cancer	0.000199	0.000507	CcSEcCtD
Hydroxychloroquine—Vision blurred—Doxorubicin—kidney cancer	0.000194	0.000494	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Capecitabine—kidney cancer	0.000192	0.000489	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CTNNA1—kidney cancer	0.000191	0.000941	CbGpPWpGaD
Hydroxychloroquine—Anaemia—Doxorubicin—kidney cancer	0.000191	0.000485	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—HSPB1—kidney cancer	0.00019	0.000936	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—EIF4EBP1—kidney cancer	0.00019	0.000936	CbGpPWpGaD
Hydroxychloroquine—Agitation—Doxorubicin—kidney cancer	0.00019	0.000482	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—RAF1—kidney cancer	0.000189	0.000933	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—PTGS1—kidney cancer	0.000189	0.000933	CbGpPWpGaD
Hydroxychloroquine—Nausea—Paclitaxel—kidney cancer	0.000189	0.000481	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—RELA—kidney cancer	0.000188	0.000929	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Capecitabine—kidney cancer	0.000187	0.000476	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—ERBB2—kidney cancer	0.000187	0.000923	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD8A—kidney cancer	0.000187	0.000922	CbGpPWpGaD
Hydroxychloroquine—Vertigo—Doxorubicin—kidney cancer	0.000185	0.000471	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—MTOR—kidney cancer	0.000185	0.000911	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Capecitabine—kidney cancer	0.000185	0.00047	CcSEcCtD
Hydroxychloroquine—Leukopenia—Doxorubicin—kidney cancer	0.000185	0.000469	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—CD4—kidney cancer	0.000184	0.00091	CbGpPWpGaD
Hydroxychloroquine—Loss of consciousness—Doxorubicin—kidney cancer	0.000181	0.000461	CcSEcCtD
Hydroxychloroquine—Convulsion—Doxorubicin—kidney cancer	0.000179	0.000454	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Capecitabine—kidney cancer	0.000179	0.000454	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—KIT—kidney cancer	0.000178	0.000876	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PSMD7—kidney cancer	0.000176	0.00087	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TSC1—kidney cancer	0.000176	0.00087	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ANXA1—kidney cancer	0.000176	0.00087	CbGpPWpGaD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000174	0.000443	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—CDKN1B—kidney cancer	0.000173	0.000855	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Capecitabine—kidney cancer	0.000173	0.000439	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—MAPK3—kidney cancer	0.000173	0.000851	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000171	0.000844	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—FLT1—kidney cancer	0.000171	0.000843	CbGpPWpGaD
Hydroxychloroquine—Oedema—Doxorubicin—kidney cancer	0.000168	0.000428	CcSEcCtD
Hydroxychloroquine—Vomiting—Capecitabine—kidney cancer	0.000166	0.000422	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—JUN—kidney cancer	0.000165	0.000814	CbGpPWpGaD
Hydroxychloroquine—Nervous system disorder—Doxorubicin—kidney cancer	0.000165	0.00042	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Doxorubicin—kidney cancer	0.000165	0.000419	CcSEcCtD
Hydroxychloroquine—Rash—Capecitabine—kidney cancer	0.000165	0.000419	CcSEcCtD
Hydroxychloroquine—Dermatitis—Capecitabine—kidney cancer	0.000164	0.000418	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—MAPK1—kidney cancer	0.000164	0.00081	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CTNNB1—kidney cancer	0.000164	0.000808	CbGpPWpGaD
Hydroxychloroquine—Headache—Capecitabine—kidney cancer	0.000164	0.000416	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CDH1—kidney cancer	0.000164	0.000806	CbGpPWpGaD
Hydroxychloroquine—Skin disorder—Doxorubicin—kidney cancer	0.000163	0.000416	CcSEcCtD
Hydroxychloroquine—Anorexia—Doxorubicin—kidney cancer	0.00016	0.000408	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—PTEN—kidney cancer	0.00016	0.000787	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—TSC2—kidney cancer	0.000159	0.000784	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—JUNB—kidney cancer	0.000158	0.000781	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PAK1—kidney cancer	0.000158	0.000781	CbGpPWpGaD
Hydroxychloroquine—Nausea—Capecitabine—kidney cancer	0.000155	0.000394	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—KRAS—kidney cancer	0.000155	0.000765	CbGpPWpGaD
Hydroxychloroquine—Somnolence—Doxorubicin—kidney cancer	0.00015	0.000381	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Doxorubicin—kidney cancer	0.000146	0.000372	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000145	0.00037	CcSEcCtD
Hydroxychloroquine—Fatigue—Doxorubicin—kidney cancer	0.000145	0.000369	CcSEcCtD
Hydroxychloroquine—Pain—Doxorubicin—kidney cancer	0.000144	0.000366	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—PIK3CA—kidney cancer	0.000142	0.000703	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—KIT—kidney cancer	0.00014	0.000693	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—GSTP1—kidney cancer	0.00014	0.00069	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—RAF1—kidney cancer	0.000139	0.000688	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—RELA—kidney cancer	0.000139	0.000685	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—GSTP1—kidney cancer	0.000138	0.000681	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—ERBB2—kidney cancer	0.000138	0.00068	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000138	0.00035	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—MAPK3—kidney cancer	0.000136	0.000673	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MTOR—kidney cancer	0.000136	0.000671	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD4—kidney cancer	0.000136	0.00067	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Doxorubicin—kidney cancer	0.000134	0.00034	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Doxorubicin—kidney cancer	0.000133	0.000338	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Doxorubicin—kidney cancer	0.000133	0.000338	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—MAPK1—kidney cancer	0.00013	0.00064	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IGF2—kidney cancer	0.000129	0.000639	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CDH1—kidney cancer	0.000129	0.000637	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CDKN2B—kidney cancer	0.000129	0.000636	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—GSTM1—kidney cancer	0.000129	0.000634	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CDKN1B—kidney cancer	0.000128	0.00063	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	0.000127	0.000626	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IGF1R—kidney cancer	0.000125	0.000617	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL2—kidney cancer	0.000125	0.000617	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Doxorubicin—kidney cancer	0.000124	0.000315	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—KRAS—kidney cancer	0.000123	0.000605	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	0.000122	0.000601	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—JUN—kidney cancer	0.000122	0.0006	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Doxorubicin—kidney cancer	0.000121	0.000307	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CTNNB1—kidney cancer	0.000121	0.000595	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	0.00012	0.000593	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Doxorubicin—kidney cancer	0.000119	0.000303	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—PTEN—kidney cancer	0.000118	0.00058	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Doxorubicin—kidney cancer	0.000115	0.000293	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—PIK3CA—kidney cancer	0.000113	0.000555	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Doxorubicin—kidney cancer	0.000111	0.000283	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—RAF1—kidney cancer	0.00011	0.000544	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—RELA—kidney cancer	0.00011	0.000541	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—ERBB2—kidney cancer	0.000109	0.000538	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—MTOR—kidney cancer	0.000108	0.000531	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD4—kidney cancer	0.000107	0.00053	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ACY1—kidney cancer	0.000107	0.000529	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Doxorubicin—kidney cancer	0.000107	0.000272	CcSEcCtD
Hydroxychloroquine—Rash—Doxorubicin—kidney cancer	0.000106	0.00027	CcSEcCtD
Hydroxychloroquine—Dermatitis—Doxorubicin—kidney cancer	0.000106	0.00027	CcSEcCtD
Hydroxychloroquine—Headache—Doxorubicin—kidney cancer	0.000105	0.000268	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—HIF1A—kidney cancer	0.000103	0.000508	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TSC2—kidney cancer	0.000103	0.000507	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CDKN1B—kidney cancer	0.000101	0.000498	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MAPK3—kidney cancer	0.000101	0.000496	CbGpPWpGaD
Hydroxychloroquine—Nausea—Doxorubicin—kidney cancer	0.0001	0.000254	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—IL2—kidney cancer	9.88e-05	0.000487	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KDR—kidney cancer	9.86e-05	0.000486	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—JUN—kidney cancer	9.61e-05	0.000474	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MAPK1—kidney cancer	9.56e-05	0.000472	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CTNNB1—kidney cancer	9.54e-05	0.000471	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PTEN—kidney cancer	9.3e-05	0.000459	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PDHB—kidney cancer	9.12e-05	0.00045	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—POMC—kidney cancer	9.09e-05	0.000448	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KIT—kidney cancer	9.08e-05	0.000448	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—APC—kidney cancer	9.08e-05	0.000448	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—KRAS—kidney cancer	9.03e-05	0.000445	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—POMC—kidney cancer	8.64e-05	0.000426	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CCBL1—kidney cancer	8.58e-05	0.000423	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—BRAF—kidney cancer	8.54e-05	0.000421	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PIK3CA—kidney cancer	8.3e-05	0.000409	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—MAPK3—kidney cancer	7.95e-05	0.000392	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—MAPK1—kidney cancer	7.56e-05	0.000373	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GLIPR1—kidney cancer	7.44e-05	0.000367	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PPAT—kidney cancer	7.44e-05	0.000367	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—KRAS—kidney cancer	7.14e-05	0.000352	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—RAF1—kidney cancer	7.13e-05	0.000351	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—RELA—kidney cancer	7.09e-05	0.00035	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ERBB2—kidney cancer	7.05e-05	0.000348	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MTOR—kidney cancer	6.96e-05	0.000343	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—FH—kidney cancer	6.91e-05	0.000341	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—APRT—kidney cancer	6.91e-05	0.000341	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PIK3CA—kidney cancer	6.56e-05	0.000324	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CDKN1B—kidney cancer	6.53e-05	0.000322	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GPC3—kidney cancer	6.5e-05	0.000321	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL2—kidney cancer	6.39e-05	0.000315	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CA2—kidney cancer	6.32e-05	0.000312	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CCND1—kidney cancer	6.23e-05	0.000307	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—JUN—kidney cancer	6.22e-05	0.000307	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CTNNB1—kidney cancer	6.17e-05	0.000304	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ALAD—kidney cancer	6.16e-05	0.000304	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ST3GAL2—kidney cancer	6.01e-05	0.000297	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PTEN—kidney cancer	6.01e-05	0.000297	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ALDH1A1—kidney cancer	5.88e-05	0.00029	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PGK1—kidney cancer	5.63e-05	0.000278	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SLC5A3—kidney cancer	5.63e-05	0.000278	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—LDHB—kidney cancer	5.53e-05	0.000273	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—VEGFA—kidney cancer	5.43e-05	0.000268	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MAPK3—kidney cancer	5.14e-05	0.000253	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MYC—kidney cancer	5e-05	0.000246	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MAPK1—kidney cancer	4.89e-05	0.000241	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CA9—kidney cancer	4.79e-05	0.000236	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KRAS—kidney cancer	4.62e-05	0.000228	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CA—kidney cancer	4.24e-05	0.000209	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TP53—kidney cancer	4.1e-05	0.000202	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CRABP1—kidney cancer	4.07e-05	0.000201	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ITPR2—kidney cancer	3.79e-05	0.000187	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ACHE—kidney cancer	3.45e-05	0.00017	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTT1—kidney cancer	3.45e-05	0.00017	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SCARB1—kidney cancer	3.27e-05	0.000161	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PTGS1—kidney cancer	3.24e-05	0.00016	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PSMD7—kidney cancer	3.17e-05	0.000157	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—BCHE—kidney cancer	3.01e-05	0.000148	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SLC5A5—kidney cancer	2.97e-05	0.000147	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SLC2A1—kidney cancer	2.87e-05	0.000142	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTP1—kidney cancer	2.39e-05	0.000118	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ABCB1—kidney cancer	2.27e-05	0.000112	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTM1—kidney cancer	2.2e-05	0.000108	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP1A1—kidney cancer	2.09e-05	0.000103	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—POMC—kidney cancer	1.55e-05	7.67e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PTGS2—kidney cancer	1.24e-05	6.12e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PTEN—kidney cancer	1.08e-05	5.33e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CA—kidney cancer	7.63e-06	3.76e-05	CbGpPWpGaD
